WUHN OTC
Wuhan General Group (China), Inc.
1W: -0.0%
1M: -33.3%
3M: -33.3%
YTD: +100.0%
1Y: +100.0%
3Y: -99.7%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.000500000024
Volume156,400
Avg Volume1,503
Beta-1.21
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJeff Robinson
Employees700
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2006-04-19
Websitewuhn.org
401 Ryland St. Ste 200-A
Reno, NV 89502
US
Reno, NV 89502
US
514-928-7368
About Wuhan General Group (China), Inc.
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.
Latest News
No recent news
Recent Insider Trades
No insider trades found